mycoside A: major phenolic glycolipid from Mycobacterium kansasii [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 165898 |
| MeSH ID | M0146843 |
| Synonym |
|---|
| mycoside a |
| 11033-70-8 |
| [29-[4-[4-[4-[5-acetyloxy-4-(4-hydroxy-5-methoxy-6-methyloxan-2-yl)oxy-3-methoxy-6-methyloxan-2-yl]oxy-5-hydroxy-3-methoxy-6-methyloxan-2-yl]oxy-3,5-dimethoxy-6-methyloxan-2-yl]oxyphenyl]-3-methoxy-4-methyl-9-(2,4,6,8-tetramethylhexacosanoyloxy)nonacosan- |
| 2,6-dideoxy-4-o-methyl-arabino-hexopyranosyl(1-3)-2-o-methyl-4-o-acetylfucopyranosyl(1-3)-2-o-methylrhamnopyranosyl(1-3)-2,4-di-o-methylrhamnopyranosyl-1-phenolglycol |
| alpha-l-mannopyranoside, 4-(27-methoxy-26-methyl-19,21-bis((2,4,6,8-tetramethyl-1-oxohexacosyl)oxy)nonacosyl)phenyl o-2,6-dideoxy-4-o-methyl-alpha-l-arabino-hexopyranosyl-(1-3)-o-4-o-acetyl-6-deoxy-2-o-methyl-alpha-l-galactopyranosyl-(1.fwdar) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.28) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||